- Letter to the editor: Coffee consumption and bone health: A risk assessment
-
Kawada T
- KMID: 2503799
- Osteoporos Sarcopenia.
- 2020 Mar;6(1):33-33.
- doi: 10.1016/j.afos.2020.02.005
-
- CITED
-
- Close
- SHARE
-
- Close
- Reply on "Coffee consumption and bone health: A risk assessment"
-
Coronado-Zarco R, Leon AOGd
- KMID: 2503800
- Osteoporos Sarcopenia.
- 2020 Mar;6(1):34-35.
- doi: 10.1016/j.afos.2020.02.006
-
- CITED
-
- Close
- SHARE
-
- Close
- Management of glucocorticoid-related osteoporotic vertebral fracture
-
Wong SPY, Mok CC
- KMID: 2503794
- Osteoporos Sarcopenia.
- 2020 Mar;6(1):1-7.
- doi: 10.1016/j.afos.2020.02.002
The vertebral column is the most common site of osteoporotic fractures in long-term users of glucocorticoids. Vertebral fracture leads to significant morbidities such as unrelenting pain, spinal deformities and reduced... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of treatment interruption due to patient convenience on treatment of once a week teriparatide
-
Katahira G, Akiba K, Takada J, Iba K, Yamashita T
- KMID: 2503795
- Osteoporos Sarcopenia.
- 2020 Mar;6(1):8-14.
- doi: 10.1016/j.afos.2020.01.001
Objectives: Once-weekly teriparatide (W-TPTD) is an effective drug for patients with osteoporosis; however, some patients discontinue W-TPTD owing to its adverse drug reactions (ADRs). Sequential treatment with W-TPTD and antiresorptive... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of falls in postmenopausal women treated with romosozumab: Preliminary indices from a meta-analysis of randomized, controlled trials
-
M€ockel L, Bartneck M, M€ockel C
- KMID: 2503797
- Osteoporos Sarcopenia.
- 2020 Mar;6(1):20-26.
- doi: 10.1016/j.afos.2020.02.003
Objectives: Falls are the well-known risk factor for osteoporotic fractures and some medications can increase the risk of falls. Therefore, the aim of our study is to evaluate the effect... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between elcatonin use and cancer risk in Japan: A followup study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis
-
Okamoto H, Shibazaki N, Yoshimura T, Uzawa T, Sugimoto T
- KMID: 2503796
- Osteoporos Sarcopenia.
- 2020 Mar;6(1):15-19.
- doi: 10.1016/j.afos.2020.02.001
Objectives: On July 20, 2012, the European Medicines Agency (EMA) provided a recommendation that limits the long-term use of calcitonin. Based on this recommendation, we investigate the presence or absence... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessing lifestyle-related diseases with body and muscle mass using bioelectrical impedance analysis
-
Miyagami T, Yokokawa H, Fujibayashi K, Fukuda H, Hisaoka T, Naito T
- KMID: 2503798
- Osteoporos Sarcopenia.
- 2020 Mar;6(1):27-32.
- doi: 10.1016/j.afos.2020.02.004
Objectives: To investigate the correlation between imbalance of muscle mass to body weight and lifestyle-related diseases using bioelectrical impedance analysis (BIA) among Japanese population. Methods: This was a retrospective, cross-sectional study... -
- CITED
-
- Close
- SHARE
-
- Close
